Healthcare Services Investing

An analysis by the Wall Street Journal of healthcare spend over the past several decades reveals the price of healthcare continues to increase faster than the consumer price index, with health spending primarily driven by hospital and physician services.


Continue Reading Analysis of Healthcare Spending Over Past Several Decades Reveals Noteworthy Trends

Unilife Corp. has announced it has secured $60 million in debt financing.

Unilife, headquartered in York, Pa., is a developer and supplier of injectable drug delivery systems.

The financing will come from an affiliate of OrbiMed, a New

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Unilife Secures $60 Million in Financing

Republicans in the House are expected to vote this week on legislation that would permanently repeal the sustainable growth rate (SGR) Medicare physician payment formula.

To pay for the SGR fix, the legislation is expected to propose a delay or

Continue Reading House Republications Expected to Propose SGR Repeal Funded by Delaying Individual Mandate

We have previously discussed on this blog the ever-increasing federal and state focus on healthcare fraud prevention and enforcement activities.

As investors consider opportunities, especially those in more highlighted areas of sensitivity, they should be aware of the government’s focus

Continue Reading Private Equity Investors Should Be Aware of Government Healthcare Fraud Enforcement Activity

Cheetah Medical has announced it has raised $9 million in financing. 

Cheetah Medical, based in Newton Center, Mass., is a developer of non-invasive hemodynamic monitoring, including the CHEETAH NICOM hemodynamic management system.

Leading the investment round was Fletcher Spaght

Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Cheetah Medical Completes $9 Million in Financing

DaVita HealthCare Partners has announced in an earnings call with shareholders that it will settle federal anti-kickback investigations into some of the company’s relationships with nephrologists, according to a Denver Post report.

Under the terms of the settlement, Denver-based

Continue Reading DaVita to Pay Nearly $400 Million to Settle Anti-Kickback Investigations